Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Continuing Education
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Continuing Education
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow JNM on Twitter
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Subscribe to our RSS feeds

cancer

  • Single-Domain Antibody Nuclear Imaging Allows Noninvasive Quantification of LAG-3 Expression by Tumor-Infiltrating Leukocytes and Predicts Response of Immune Checkpoint Blockade
    Open Access
    Single-Domain Antibody Nuclear Imaging Allows Noninvasive Quantification of LAG-3 Expression by Tumor-Infiltrating Leukocytes and Predicts Response of Immune Checkpoint Blockade
    Quentin Lecocq, Robin Maximilian Awad, Yannick De Vlaeminck, Wout de Mey, Thomas Ertveldt, Cleo Goyvaerts, Geert Raes, Kris Thielemans, Marleen Keyaerts, Nick Devoogdt and Karine Breckpot
    Journal of Nuclear Medicine November 1, 2021, 62 (11) 1638-1644; DOI: https://doi.org/10.2967/jnumed.120.258871
  • You have access
    PET/MRI Improves Management of Children with Cancer
    Lucia Baratto, K. Elizabeth Hawk, Lisa States, Jing Qi, Sergios Gatidis, Louise Kiru and Heike E. Daldrup-Link
    Journal of Nuclear Medicine October 1, 2021, 62 (10) 1334-1340; DOI: https://doi.org/10.2967/jnumed.120.259747
  • 
<sup>89</sup>Zr-Labeled Anti-PD-L1 Antibody PET Monitors Gemcitabine Therapy-Induced Modulation of Tumor PD-L1 Expression
    You have access
    89Zr-Labeled Anti-PD-L1 Antibody PET Monitors Gemcitabine Therapy-Induced Modulation of Tumor PD-L1 Expression
    Kyung-Ho Jung, Jin Won Park, Jin Hee Lee, Seung Hwan Moon, Young Seok Cho and Kyung-Han Lee
    Journal of Nuclear Medicine May 10, 2021, 62 (5) 656-664; DOI: https://doi.org/10.2967/jnumed.120.250720
  • You have access
    Optical Imaging Modalities: Principles and Applications in Preclinical Research and Clinical Settings
    Giacomo Pirovano, Sheryl Roberts, Susanne Kossatz and Thomas Reiner
    Journal of Nuclear Medicine October 1, 2020, 61 (10) 1419-1427; DOI: https://doi.org/10.2967/jnumed.119.238279
  • You have access
    Imaging the Distribution of Gastrin-Releasing Peptide Receptors in Cancer
    Lucia Baratto, Heying Duan, Helmut Mäcke and Andrei Iagaru
    Journal of Nuclear Medicine June 1, 2020, 61 (6) 792-798; DOI: https://doi.org/10.2967/jnumed.119.234971
  • You have access
    Long-Term Clinical and Neuronuclear Imaging Sequelae of Cancer Therapy, Trauma, and Brain Injury
    April Alcantara, Gholam R. Berenji, Carole S. Scherling, Beata Durcanova, Daniel Diaz-Aguilar and Daniel H.S. Silverman
    Journal of Nuclear Medicine December 1, 2019, 60 (12) 1682-1690; DOI: https://doi.org/10.2967/jnumed.119.237578
  • You have access
    Prediction of Time to Hormonal Treatment Failure in Metastatic Castration-Sensitive Prostate Cancer with 18F-FDG PET/CT
    Hossein Jadvar, Erik M. Velez, Bhushan Desai, Lingyun Ji, Patrick M. Colletti and David I. Quinn
    Journal of Nuclear Medicine November 1, 2019, 60 (11) 1524-1530; DOI: https://doi.org/10.2967/jnumed.118.223263
  • Open Access
    Tumor Imaging Using Radiolabeled Matrix Metalloproteinase–Activated Anthrax Proteins
    Mary-Ann Elvina Xavier, Shihui Liu, Thomas H. Bugge, Julia Baguña Torres, Michael Mosley, Samantha L. Hopkins, Phillip D. Allen, Georgina Berridge, Iolanda Vendrell, Roman Fischer, Veerle Kersemans, Sean Smart, Stephen H. Leppla and Bart Cornelissen
    Journal of Nuclear Medicine October 1, 2019, 60 (10) 1474-1482; DOI: https://doi.org/10.2967/jnumed.119.226423
  • You have access
    Early Postoperative 18F-FET PET/MRI for Pediatric Brain and Spinal Cord Tumors
    Lisbeth Marner, Karsten Nysom, Astrid Sehested, Lise Borgwardt, René Mathiasen, Otto Mølby Henriksen, Michael Lundemann, Per Munck af Rosenschöld, Carsten Thomsen, Lars Bøgeskov, Jane Skjøth-Rasmussen, Marianne Juhler, Anders Kruse, Helle Broholm, David Scheie, Torsten Lauritsen, Julie Lyng Forman, Peder Skov Wehner, Liselotte Højgaard and Ian Law
    Journal of Nuclear Medicine August 1, 2019, 60 (8) 1053-1058; DOI: https://doi.org/10.2967/jnumed.118.220293
  • You have access
    Quantitative Tumor Perfusion Imaging with 82Rb PET/CT in Prostate Cancer: Analytic and Clinical Validation
    Mads R. Jochumsen, Lars P. Tolbod, Bodil G. Pedersen, Maria M. Nielsen, Søren Høyer, Jørgen Frøkiær, Michael Borre, Kirsten Bouchelouche and Jens Sörensen
    Journal of Nuclear Medicine August 1, 2019, 60 (8) 1059-1065; DOI: https://doi.org/10.2967/jnumed.118.219188

Pages

  • Previous
  • Next
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
SNMMI

© 2023 Journal of Nuclear Medicine

Powered by HighWire